New drug trial offers hope for kids with rare eye disorder
NCT ID NCT07298928
Summary
This study is testing whether a drug called Telitacicept can help children with ocular myasthenia gravis, a condition that causes eye muscle weakness and drooping eyelids. The trial will involve 30 children under 18 who are already receiving standard treatments. Researchers want to see if this medication can better control symptoms and allow children to reduce or stop steroid medications that often cause side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EFFECTIVENESS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital Affiliated to Shandong University
Jinan, Shandong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shenzhen children's Hospital of China Medical University
Shenzhen, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Children's Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310052, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.